Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jul 8;16:1769–1776. doi: 10.2147/CCID.S414011

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 Benedusi et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Preventive role of M89PF on the skin barrier-associated protein Involucrin. Involucrin expression levels in skin explants samples exposed to O₃, UV, O₃+ UV and/or pretreated topically with M89PF for 24h and analyzed at DAY 1 (A) or DAY 4 (B). Magnification 40X. Scale bar 100 μm. Right panels shown the quantification of relative immunofluorescence staining for Involucrin after different treatments (DAY 1; DAY4). Data are expressed as the mean of the three different subjects ± standard deviation. *p≤0.05 Ctrl vs Pollutant; ^#p≤0.05 M89PF + Pollutant vs Corresponding pollutant. One-way ANOVA followed by Bonferroni post hoc test.